AcquisitionOther
OS Therapies Inc. acquired Advaxis Immunotherapies assets from Ayala Pharmaceuticals
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
OS Therapies Inc. -> Advaxis Immunotherapies assets from Ayala Pharmaceuticals
To consolidate listeria cancer immunotherapy platform and expand immunotherapy capabilities.
Open source record (SEC) ↗